George Budwell

George Budwell


George Budwell has been writing about healthcare and biotechnology companies at the Motley Fool since 2013. His primary interests are novel small molecule drugs, next generation vaccines, and cell therapies.

Recent articles

3 Top Biotech Stocks for 2018

Celgene Corp., Juno Therapeutics, and Cara Therapeutics are three biotech stocks to watch in 2018.

3 Stocks Changing the Future of Healthcare

If you're on the hunt for companies developing game-changing medical technologies, Apple, Bellicum Pharmaceuticals, and Novocure need to be on your radar.

3 High-Yield International Stocks

These three foreign dividend stocks could be great buys right now. Here's why.